We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Top Buys

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.7M
2
IMVT icon
Immunovant
IMVT
+$15.7M
3
LL
LL Flooring Holdings, Inc.
LL
+$11.4M
4
ACET icon
Adicet Bio
ACET
+$10.9M
5
INVZ icon
Innoviz Technologies
INVZ
+$9.95M

Top Sells

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$131M
2
IMCR icon
Immunocore
IMCR
+$34.1M
3
FTAI icon
FTAI Aviation
FTAI
+$28.1M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$20.8M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIST icon
701
Milestone Pharmaceuticals
MIST
$157M
– –
-14,000
Closed -$20K
MLCO icon
702
Melco Resorts & Entertainment
MLCO
$2.12B
– –
-60,000
Closed -$30K
MO icon
703
Altria Group
MO
$109B
– –
-25,300
Closed -$1K
MPT
704
Medical Properties Trust
MPT
$2.48B
– –
-11,100
Closed -$4K
MX icon
705
Magnachip Semiconductor
MX
$142M
– –
-40,800
Closed -$394K
NTNX icon
706
Nutanix
NTNX
$17.4B
– –
-10,000
Closed -$2K
PACB icon
707
Pacific Biosciences
PACB
$361M
– –
-84,400
Closed -$41K
PCT icon
708
PureCycle Technologies
PCT
$1.48B
– –
-30,097
Closed -$217K
PLTK icon
709
Playtika
PLTK
$1B
– –
-975,000
Closed -$9.15M
PYPL icon
710
PayPal
PYPL
$50.4B
– –
-16,708
Closed -$1.44M
QQQ icon
711
Invesco QQQ Trust
QQQ
$478B
– –
-30,000
Closed -$8.3M
RVTY icon
712
Revvity
RVTY
$12.9B
– –
-1,674
Closed -$201K
FLNA
713
Filana Therapeutics
FLNA
$47.8M
– –
-19,467
Closed -$187K
SCLXW icon
714
Scilex Holding Co Warrant
SCLXW
– –
-49,596
Closed -$8K
SKIN icon
715
SkinHealth Systems
SKIN
$86.3M
– –
-20,000
Closed -$14K
SMH icon
716
VanEck Semiconductor ETF
SMH
$70.4B
– –
-146,000
Closed -$487K
SMMT icon
717
Summit Therapeutics
SMMT
$11.9B
– –
-17,249
Closed -$21K
SPY icon
718
State Street SPDR S&P 500 ETF Trust
SPY
$808B
– –
-37,500
Closed -$14.4M
STE icon
719
Steris
STE
$23.4B
– –
-1,878
Closed -$312K
TARS icon
720
Tarsus Pharmaceuticals
TARS
$3.02B
– –
-522,329
Closed -$8.94M
TDW icon
721
Tidewater
TDW
$4.51B
– –
-25,353
Closed -$550K
TGTX icon
722
TG Therapeutics
TGTX
$7.63B
– –
-112,000
Closed -$813K
TLT icon
723
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
– –
-100,235
Closed -$122K
VYX icon
724
NCR Voyix
VYX
$1.12B
– –
-132,030
Closed -$543K
WAT icon
725
Waters Corp
WAT
$40.6B
– –
-915
Closed -$247K
27 28
29
30 31

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.